Mutational analysis of activin/transforming growth factor-β type I and type II receptor kinases in human pituitary tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 5, 1999, Pages 1716-1721

  D'Abronzo, F Homero ^d   Swearingen, Brooke ^a   Klibanski, Anne ^b   Alexander, Joseph M ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; CELL SURFACE RECEPTOR; FOLLITROPIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TYROSINE KINASE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; FOLLITROPIN RELEASE; GENE INACTIVATION; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HEP 2 CELL; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

EID: 0033349356     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.5.5704     Document Type: Article

References (37)

1. Activin receptors and cellular signaling by the receptor serine kinase family
2. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β
3. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin
4. Tumor-specific expression and alternate splicing of mRNAs encoding activin/transforming growth factor-β receptors in human piutitary adenomas
5. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids
6. Decreased follistatin gene expression in gonadotroph adenomas
7. TGF-β signalling from cell membrane to nucleus through SMAD proteins
8. Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylahon of RB protein and the concomitant block of cell cycle at G1 phase
9. Human recombinant activin-A inhibits proliferation of human fetal adrenal cells in vitro
10. Mechanism of activation of the TGF-β receptor
11. Molecular cloning and binding properties of the human type II activin receptor
12. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor
13. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
14. Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinas activity
15. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGF β type II receptor
16. Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro
17. Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells
18. The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas
19. Somatostatin receptor subtype gene expression in pituitary adenomas
20. Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro
21. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
22. Loss of receptors for transforming growth factor β in human T-cell malignancies
23. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
24. Genetic changes in the transforming growth factor beta (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β
25. Formation and activation by phosphorylation of activin receptor complexes
26. Identification of human activin and TGF β type I receptors that form heteromeric kinase complexes with type II receptors
27. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin
28. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells
29. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4
30. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
31. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains
32. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region
33. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway
34. A transcriptional partner for MAD proteins in TGF-β signalling
35. Receptor-associated Mad homologues synergize as effectors of the TGF-β response
36. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated In colorectal carcinoma
37. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1